BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23897588)

  • 1. Participation in cancer clinical trials: why are patients not participating?
    Byrne MM; Tannenbaum SL; Glück S; Hurley J; Antoni M
    Med Decis Making; 2014 Jan; 34(1):116-26. PubMed ID: 23897588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients.
    Kaplan CP; Nápoles AM; Narine S; Gregorich S; Livaudais-Toman J; Nguyen T; Leykin Y; Roach M; Small EJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):443-448. PubMed ID: 26435199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.
    Advani AS; Atkeson B; Brown CL; Peterson BL; Fish L; Johnson JL; Gockerman JP; Gautier M
    Cancer; 2003 Mar; 97(6):1499-506. PubMed ID: 12627515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups.
    Burnett-Hartman AN; Blum-Barnett E; Carroll NM; Madrid SD; Jonas C; Janes K; Alvarado M; Bedoy R; Paolino V; Aziz N; McGlynn EA
    Public Health Genomics; 2020; 23(1-2):59-68. PubMed ID: 32289795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic differences in willingness to participate in psychiatric genetic research.
    Murphy EJ; Wickramaratne P; Weissman MM
    Psychiatr Genet; 2009 Aug; 19(4):186-94. PubMed ID: 19593860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups.
    Lim BT; Butow P; Sze ML; Girgis A; Jefford M; Goldstein D; Costa D
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):115-122. PubMed ID: 31957344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.
    Adams DV; Long S; Fleury ME
    JAMA Netw Open; 2022 Jul; 5(7):e2220053. PubMed ID: 35788672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial participation. Viewpoints from racial/ethnic groups.
    Roberson NL
    Cancer; 1994 Nov; 74(9 Suppl):2687-91. PubMed ID: 7954287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in factors that influence the willingness to participate in medical research studies.
    Shavers VL; Lynch CF; Burmeister LF
    Ann Epidemiol; 2002 May; 12(4):248-56. PubMed ID: 11988413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives.
    Langford AT; Hawley ST; Stableford S; Studts JL; Byrne MM
    J Cancer Educ; 2020 Jun; 35(3):454-461. PubMed ID: 30739270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors.
    Langford A; Studts JL; Byrne MM
    Patient Educ Couns; 2021 Feb; 104(2):422-426. PubMed ID: 32660742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.
    Smith A'; Agar M; Delaney G; Descallar J; Dobell-Brown K; Grand M; Aung J; Patel P; Kaadan N; Girgis A
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):52-60. PubMed ID: 29083094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors.
    Kumar G; Kim J; Farazi PA; Wang H; Su D
    BMC Cancer; 2022 Sep; 22(1):983. PubMed ID: 36109780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
    Priddy FH; Cheng AC; Salazar LF; Frew PM
    Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.
    Jacobsen PB; Wells KJ; Meade CD; Quinn GP; Lee JH; Fulp WJ; Gray JE; Baz RC; Springett GM; Levine RM; Markham MJ; Schreiber FJ; Cartwright TH; Burke JM; Siegel RD; Malafa MP; Sullivan D
    J Clin Oncol; 2012 Jul; 30(20):2516-21. PubMed ID: 22614993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.
    Unger JM; Hershman DL; Till C; Minasian LM; Osarogiagbon RU; Fleury ME; Vaidya R
    J Natl Cancer Inst; 2021 Mar; 113(3):244-257. PubMed ID: 33022716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
    Aristizabal P; Singer J; Cooper R; Wells KJ; Nodora J; Milburn M; Gahagan S; Schiff DE; Martinez ME
    Pediatr Blood Cancer; 2015 Aug; 62(8):1337-44. PubMed ID: 25755225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
    Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.